SENATE DOCKET, NO. 777 FILED ON: 1/18/2017
SENATE . . . . . . . . . . . . . . No. 1211
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
John F. Keenan
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to review the quality and patient safety of dispensing certain cancer and chronic disease related drugs.
_______________
PETITION OF:
Name: | District/Address: |
|
John F. Keenan | Norfolk and Plymouth |
|
Danielle W. Gregoire | 4th Middlesex | 2/2/2017 |
Kate Hogan | 3rd Middlesex | 2/3/2017 |
James J. O'Day | 14th Worcester | 2/3/2017 |
SENATE DOCKET, NO. 777 FILED ON: 1/18/2017
SENATE . . . . . . . . . . . . . . No. 1211
By Mr. Keenan, a petition (accompanied by bill, Senate, No. 1211) of John F. Keenan, Danielle W. Gregoire, Kate Hogan and James J. O'Day for legislation to review the quality and patient safety of dispensing certain cancer and chronic disease related drugs. Public Health. |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninetieth General Court
(2017-2018)
_______________
An Act to review the quality and patient safety of dispensing certain cancer and chronic disease related drugs.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. The health policy commission, in consultation with the department of public health and the division of insurance, shall study and analyze health insurance payer practices that require certain categories of drugs, including those that are administered by injection or infusion, to be dispensed by a third-party specialty pharmacy directly to a patient or to a health care provider with the designation that such drugs be used for a specific patient and not for the general use of the provider. The commission shall file a report of its findings, including recommended legislation, with the senate and house committees on ways and means, the joint committee on health care financing and the joint committee on public health not later than January 1, 2018.